A Follow-up Study to Evaluate Actinic Keratosis Recurrence Rates One Year After Completion of the 1487-IMIQ Study
Phase 3
18 Years
N/A
18 Years
N/A
Not Enrolling
Both
Actinic Keratoses
Both
Actinic Keratoses
Trial Information
A Follow-up Study to Evaluate Actinic Keratosis Recurrence Rates One Year After Completion of the 1487-IMIQ Study
Inclusion Criteria:
- 100% clearance of Actinic Keratosis (AK) lesions in the 1487 IMIQ study
Exclusion Criteria:
- used any treatments in the previous treatment area within 24 hours prior to the
follow-up visit
Type of Study:
Observational
Study Design:
Observational Model: Defined Population, Observational Model: Natural History, Time Perspective: Longitudinal, Time Perspective: Prospective
Principal Investigator
Study Coordinator
Investigator Role:
Study Chair
Investigator Affiliation:
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Authority:
United States: Food and Drug Administration
Study ID:
1524-IMIQ
NCT ID:
NCT00189254
Start Date:
April 2005
Completion Date:
Related Keywords:
- Actinic Keratoses
- 1 year follow up
- Keratosis
- Keratosis, Actinic
- Recurrence
Name | Location |
|---|
